FBLG

FibroBiologics, Inc. Common Stock

Insider Trades

NameValueActionPriceCurrent Price
Khoja HamidChief Scientific Officer
$11k30k shares
BuyMar 4, 2026
$0.38
--
O'heeron PeteDirector, Officer: CHIEF EXECUTIVE OFFICER
$6.0k15.9k shares
BuyMar 4, 2026
$0.3784
--
O'heeron PeteDirector, Officer: CHIEF EXECUTIVE OFFICER
$7.4k18.2k shares
BuyMar 3, 2026
$0.4051
--
Davis JasonChief Financial Officer
$29k70k shares
BuyMar 2, 2026
$0.4139
--
O'heeron PeteDirector, Officer: CHIEF EXECUTIVE OFFICER
$6.2k17.4k shares
BuyMar 2, 2026
$0.353
--
Garcia Ruben AGeneral Counsel
$13k40k shares
BuyFeb 27, 2026
$0.3264
--

News

globenewswire.comFibroBiologics Advances Patient Dosing for Phase 1/2 Clinical Trial of CYWC628 for the Treatment of Diabetic Foot Ulcersglobenewswire.comJun 16globenewswire.comFibroBiologics Announces First Patients Dosed in Phase 1/2 Clinical Trial Evaluating CYWC628 for the Treatment of Diabetic Foot Ulcersglobenewswire.comJun 3feeds.benzinga.comEXCLUSIVE: FibroBiologics Doses First Patients In Diabetic Foot Ulcers Clinical Trialfeeds.benzinga.comJun 3globenewswire.comFibroBiologics Presents Preclinical Data Demonstrating Durable Immunomodulation in Psoriasis at the Society for Investigative Dermatology 2026 Annual Meetingglobenewswire.comMay 22globenewswire.comFibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeuticsglobenewswire.comMay 18